We are at the dawn of a new era: the omic era. New ‘omic’ technologies revolutionize medicine and lifestyle by producing large datasets for the molecular analysis of human samples. OmicEra Diagnostics aims to catalyze this revolution. At OmicEra we offer cutting-edge mass spectrometry-based analyses of human samples, ranging from plasma, CSF or urine to any type of FFPE and frozen tissue collection. Powered by innovative AI technology, our results maximize biomedical insights. This helps our clients to improve their research pipelines and discover more reliable and valuable biomarkers. Our interdisciplinary team is fueled by a diverse knowledgebase, including leading proteomic scientists, bioinformaticians and serial entrepreneurs. Together, we aim to change the way we think about medical diagnostics and implement the latest omic technologies in clinical routine.